| Literature DB >> 33832607 |
Natalie A Bello1, C Noel Bairey Merz2, Haywood Brown3, Melinda B Davis4, Neal W Dickert5, Stephanie C El Hajj6, Cindy Giullian7, Odayme Quesada8, Ki Park9, Rupa M Sanghani10, Leslee Shaw11, Annabelle Santos Volgman10, Nanette K Wenger12, Dominique Williams13, Carl J Pepine9, Kathryn J Lindley13.
Abstract
The prevalence of cardiovascular disease (CVD) in pregnancy, both diagnosed and previously unknown, is rising, and CVD is a leading cause of maternal morbidity and mortality. Historically, women of child-bearing potential have been underrepresented in research, leading to lasting knowledge gaps in the cardiovascular care of pregnant and lactating women. Despite these limitations, clinicians should be familiar with the safety of frequently used diagnostic and therapeutic interventions to adequately care for this at-risk population. This review, the fourth of a 5-part series, provides evidence-based recommendations regarding the use of common cardiovascular diagnostic tests and medications in pregnant and lactating women.Entities:
Keywords: cardio-obstetrics; imaging; lactation; medication; pregnancy
Mesh：
Substances：
Year: 2021 PMID： 33832607 PMCID： PMC8221542 DOI： 10.1016/j.jacc.2021.01.056
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094